Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Search stocks
Atul Ltd

| Quarterly Financial Results Q3 FY 2025-26

BULLISH SENTIMENT

Report Source

⬤23rd Jan 26

Summary : Atul Ltd reported strong consolidated revenue and profit growth for the nine months ended December 31, 2025, driven by its diverse chemical segments, while addressing new labor code impacts.

Quarterly Report Analysis & Insights

Financial Disclosures

  1. Cost of materials consumed is the largest expense component.
  2. Employee benefit expenses increased due to new labour codes provision.
  3. Consolidated revenue from operations for 9M ended Dec 31, 2025, was ₹ 4,603.47 crore, up from ₹ 4,131.71 crore in prior year.
  4. Segment revenue: Life Science Chemicals, Performance and Other Chemicals, Others.
  5. Consolidated total assets as of Dec 31, 2025, were ₹ 7,610.44 crore.
  6. Consolidated total liabilities as of Dec 31, 2025, were ₹ 1,474.88 crore.
  7. Paid-up equity share capital is ₹ 29.44 crore.
  8. Share of net profit of associate and joint venture companies included.
  9. Company has numerous subsidiaries, associates, and joint ventures.
  10. Both standalone and consolidated results are presented.
  11. Consolidated results show higher revenue and profit compared to standalone.

Corporate Overview

  1. Operations in India and through subsidiaries located outside India (e.g., Brazil, China, Germany, Europe, Middle East, USA).
  2. Assessing impact of new labour codes on employee benefit expenses.
  3. Manufacturing and selling active pharmaceutical ingredients, crop protection chemicals, adhesion promoters, bulk chemicals, epoxy resins, hardeners, intermediates, textile dyes, agribiotech, food products, and services.
  4. Life Science Chemicals
  5. Performance and Other Chemicals
  6. Others (Agribiotech, food products, services)

Risk Factors

  1. New labor codes impact employee expenses.
  2. Reliance on other auditors for subsidiaries.
  3. Other comprehensive income shows volatility.
  4. Regulatory changes require continuous monitoring.

Key Drivers

  1. Strong growth in Life Science Chemicals.
  2. Performance and Other Chemicals show growth.
  3. Overall revenue and profit increased significantly.
  4. Diversified product portfolio supports stability.

Auditor’s Report

  1. Limited review report, not an audit opinion.
  2. No material misstatement identified in standalone and consolidated results.
  3. Reliance on other auditors' reports for 3 subsidiaries.
  4. Reliance on management certified information for 36 unreviewed subsidiaries.
  5. Reliance on management certified information for an associate's unreviewed financial data.

Board Commentary

  1. Impact of new labour codes on employee benefit expenses.
  2. Impact of new labour codes on employee benefit expenses, requiring incremental provision.

Corporate Governance

  1. Audit Committee reviewed and recommended financial results.
  2. Audit Committee is in place.

Management Discussion & Analysis

Operational Focus Areas

  1. Monitoring finalisation of Central and State rules for new labour codes.
  2. Recognising impact of changes in estimates as needed.

Performance Drivers

  1. Increased revenue from operations across all segments.
  2. Effective management of cost of materials.
  3. Growth in profit before tax and profit for the period.

Risk Control Measures

  1. Made incremental provision for employee benefit expenses due to new labour codes.
  2. Continuously monitoring finalisation of labour code rules.

Critical Risks

  1. Impact of new labour codes on employee benefit expenses.
  2. Reliance on interim financial information certified by management for unreviewed subsidiaries.